Department of Physical Therapy, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan.
Clin Rehabil. 2012 Oct;26(10):924-33. doi: 10.1177/0269215512441484. Epub 2012 Apr 4.
To compare the short-term and medium-term effect of Functional Fascial Taping to placebo taping on pain and function in people with non-specific low back pain.
A pilot randomized controlled trial with a 2-week intervention, and 2-, 6- and 12-week follow-up.
Individuals with non-specific low back pain recruited from local communities.
Forty-three participants with non-specific low back pain for more than 6 weeks were randomized into either Functional Fascial Taping group (n = 21) or placebo group (n = 22).
The intervention group was treated with Functional Fascial Taping while the control group was treated with placebo taping. Both groups received four treatments over 2 weeks.
Worst and average pain and function were assessed at baseline, after the 2-week intervention, and at 6 and 12 weeks follow-up.
The Functional Fascial Taping group demonstrated significantly greater reduction in worst pain compared to placebo group after the 2-week intervention (P = 0.02, effect size = 0.74; 95% confidence interval 0.11-1.34). A higher proportion of participants in Functional Fascial Taping group attained the minimal clinically important difference in worst pain (P = 0.007) and function (P = 0.007) than those in placebo group after the 2-week intervention. There were no significant differences in either group's disability rating or clinically important difference in average pain at any time.
Functional Fascial Taping reduced worst pain in patients with non-acute non-specific low back pain during the treatment phase. No medium-term differences in pain or function were observed.
比较功能性筋膜贴扎与安慰剂贴扎在治疗非特异性下腰痛患者的短期和中期疗效,比较疼痛和功能。
一项为期 2 周的干预、2 周、6 周和 12 周随访的前瞻性随机对照试验。
从当地社区招募的非特异性下腰痛患者。
43 名患有非特异性下腰痛超过 6 周的患者被随机分为功能性筋膜贴扎组(n = 21)或安慰剂组(n = 22)。
干预组采用功能性筋膜贴扎治疗,对照组采用安慰剂贴扎治疗。两组均在 2 周内接受 4 次治疗。
在基线、2 周干预后、6 周和 12 周随访时,评估最差和平均疼痛和功能。
与安慰剂组相比,功能性筋膜贴扎组在 2 周干预后,最差疼痛显著减轻(P = 0.02,效应量 = 0.74;95%置信区间 0.11-1.34)。在 2 周干预后,功能性筋膜贴扎组中达到最差疼痛最小临床重要差异的患者比例(P = 0.007)和功能(P = 0.007)均高于安慰剂组。两组在任何时间的残疾评分或平均疼痛的临床重要差异均无显著差异。
功能性筋膜贴扎在治疗非急性非特异性下腰痛患者时可减轻疼痛,在治疗阶段。在疼痛或功能方面没有观察到中期差异。